ENSC
Price
$1.75
Change
-$0.13 (-6.91%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
2.64M
INDP
Price
$0.48
Change
-$0.00 (-0.00%)
Updated
Apr 17, 04:19 PM (EDT)
Capitalization
6.97M
21 days until earnings call
Ad is loading...

ENSC vs INDP

Header iconENSC vs INDP Comparison
Open Charts ENSC vs INDPBanner chart's image
Ensysce Biosciences
Price$1.75
Change-$0.13 (-6.91%)
Volume$4.43K
Capitalization2.64M
Indaptus Therapeutics
Price$0.48
Change-$0.00 (-0.00%)
Volume$500
Capitalization6.97M
ENSC vs INDP Comparison Chart
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. INDP commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and INDP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (ENSC: $1.88 vs. INDP: $0.48)
Brand notoriety: ENSC and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 443% vs. INDP: 3%
Market capitalization -- ENSC: $2.64M vs. INDP: $6.97M
ENSC [@Biotechnology] is valued at $2.64M. INDP’s [@Biotechnology] market capitalization is $6.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 0 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 0 green, 5 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENSC and INDP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 5 TA indicator(s) are bullish while INDP’s TA Score has 5 bullish TA indicator(s).

  • ENSC’s TA Score: 5 bullish, 2 bearish.
  • INDP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than INDP.

Price Growth

ENSC (@Biotechnology) experienced а +0.53% price change this week, while INDP (@Biotechnology) price change was -4.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -13.37%, and the average quarterly price growth was -24.84%.

Reported Earning Dates

ENSC is expected to report earnings on May 15, 2023.

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDP($6.97M) has a higher market cap than ENSC($2.64M). INDP YTD gains are higher at: -42.643 vs. ENSC (-76.904). ENSC has higher annual earnings (EBITDA): -6.7M vs. INDP (-15.37M). INDP has more cash in the bank: 5.79M vs. ENSC (3.5M). INDP has less debt than ENSC: INDP (84.2K) vs ENSC (302K). ENSC (0) and INDP (0) have equivalent revenues.
ENSCINDPENSC / INDP
Capitalization2.64M6.97M38%
EBITDA-6.7M-15.37M44%
Gain YTD-76.904-42.643180%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.5M5.79M61%
Total Debt302K84.2K359%
FUNDAMENTALS RATINGS
ENSC vs INDP: Fundamental Ratings
ENSC
INDP
OUTLOOK RATING
1..100
251
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9696
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INDP's Valuation (32) in the null industry is in the same range as ENSC (43). This means that INDP’s stock grew similarly to ENSC’s over the last 12 months.

INDP's Profit vs Risk Rating (95) in the null industry is in the same range as ENSC (100). This means that INDP’s stock grew similarly to ENSC’s over the last 12 months.

INDP's SMR Rating (99) in the null industry is in the same range as ENSC (100). This means that INDP’s stock grew similarly to ENSC’s over the last 12 months.

INDP's Price Growth Rating (96) in the null industry is in the same range as ENSC (96). This means that INDP’s stock grew similarly to ENSC’s over the last 12 months.

ENSC's P/E Growth Rating (98) in the null industry is in the same range as INDP (100). This means that ENSC’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCINDP
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X84033.870000364.875000
+0.44%
Bitcoin cryptocurrency
GME26.25-0.45
-1.69%
GameStop Corp
SPY525.66-11.95
-2.22%
SPDR® S&P 500® ETF
AAPL194.27-7.87
-3.89%
Apple
TSLA241.55-12.56
-4.94%
Tesla

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-16.07%
MLLCF - ENSC
40%
Loosely correlated
N/A
GNPX - ENSC
30%
Poorly correlated
-1.73%
INDP - ENSC
27%
Poorly correlated
-4.22%
HNSBF - ENSC
25%
Poorly correlated
N/A
HOWL - ENSC
24%
Poorly correlated
-1.14%
More

INDP and

Correlation & Price change

A.I.dvisor tells us that INDP and COYA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDP and COYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-4.22%
COYA - INDP
30%
Poorly correlated
-5.26%
AFMD - INDP
29%
Poorly correlated
+0.69%
NKTR - INDP
27%
Poorly correlated
-4.85%
ENSC - INDP
27%
Poorly correlated
-16.07%
ISCO - INDP
25%
Poorly correlated
-0.89%
More